Beyond the short squeeze

Equities 4 minutes to read
Eleanor Creagh

Australian Market Strategist

Summary:  Last week risk shifted very quickly to the downside, but the de-grossing (long selling & short covering) driven downside has proved as short as it was sharp.


Last week risk shifted very quickly to the downside, but the de-grossing (long selling & short covering) driven downside has proved as short as it was sharp. As we surmised last week, price action was more typical of a positioning shake out and market clearing event over a trend change. We stated the equity complex drawdown was providing opportunity to reload on reflation trades and re-establish longs in preferred stocks, sectors and geographies.

Posited against little spill over from the VIX/VXN spike and deleveraging across the equity complex into other assets classes (commodities, FX, fixed income), our position has not changed. We continue to view the correction as a short-term positioning shake out.

Post all the drama of last week, with dealer gamma back on side, equities have moved on from the short squeeze and Gamestop myopia with focus firmly upon reloading reflation trades. From previous overextended rallies the shakeout has provided a positioning refresh and opens up scope for further upside with both the VIX and VXN collapsing lower and likely continuing to do so. Continued breakdown in volatility will fuel a coincident re-grossing following the short/sharp drawdown.

4Q reports in the US show the cycle has turned and earnings are now accelerating to the upside. Across the broad S&P 500 earnings growth has increased sequentially ~4% (-7.44% 3Q), the bottom in the earnings cycle is behind us, with the global cycle now in an early expansion and companies’ earnings are surprising to the upside albeit against a  significantly lowered bar. The profit cycle has turned, and earnings are accelerating to the upside far quicker than expected. Many companies have beat expectations and will continue to do so as coming out the other side of the pandemic many resilient companies have nimbly adapted in response to the crisis and are now positioned to leverage the inbound economic recovery. Balance sheets have been bolstered, cost structures are leaner or have been optimised, and demand is rebounding and will continue to do so, particularly with vaccines now being rolled out on a large scale.

The inflection in the earnings cycle becoming a catalyst for a continued upgrade cycle in combination with the setup of growth rebounding against the backdrop of more fiscal stimulus and free flowing central bank liquidity. The economic recovery gathering steam and broadening, with growth accelerating, supportive policy trajectory and earnings rebounding all combine keeping markets hitting all-time highs amidst a fiscally fuelled reopening. With the US dollar likely to resume its decline and volatility breaking down asset managers will gross up positioning. With our preferred exposures Asia, Commodities and bets on higher long dated yields and higher inflation continuing to benefit within this regime.

Disclaimer

The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-hk/legal/disclaimer/saxo-disclaimer)

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo Capital Markets HK Limited holds a Type 1 Regulated Activity (Dealing in securities); Type 2 Regulated Activity (Dealing in Futures Contract) and Type 3 Regulated Activity (Leveraged foreign exchange trading) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong

By clicking on certain links on this site, you are aware and agree to leave the website of Saxo Capital Markets, proceed on to the linked site managed by Saxo Group and where you will be subject to the terms of that linked site.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

Please note that the information on this site and any product and services we offer are not targeted at investors residing in the United States and Japan, and are not intended for distribution to, or use by any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation. Please click here to view our full disclaimer.